OPRA vs. AZN
Compare and contrast key facts about Opera Limited (OPRA) and AstraZeneca PLC (AZN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OPRA or AZN.
Performance
OPRA vs. AZN - Performance Comparison
Returns By Period
In the year-to-date period, OPRA achieves a 50.90% return, which is significantly higher than AZN's -3.85% return.
OPRA
50.90%
20.67%
44.80%
62.31%
18.16%
N/A
AZN
-3.85%
-19.00%
-17.29%
0.98%
8.79%
8.95%
Fundamentals
OPRA | AZN | |
---|---|---|
Market Cap | $1.65B | $202.73B |
EPS | $1.77 | $2.07 |
PE Ratio | 10.36 | 30.55 |
Total Revenue (TTM) | $448.79M | $38.56B |
Gross Profit (TTM) | $238.03M | $29.12B |
EBITDA (TTM) | $97.42M | $12.81B |
Key characteristics
OPRA | AZN | |
---|---|---|
Sharpe Ratio | 1.16 | 0.07 |
Sortino Ratio | 2.04 | 0.23 |
Omega Ratio | 1.23 | 1.03 |
Calmar Ratio | 1.04 | 0.05 |
Martin Ratio | 4.60 | 0.20 |
Ulcer Index | 13.92% | 7.70% |
Daily Std Dev | 55.30% | 20.41% |
Max Drawdown | -72.85% | -48.94% |
Current Drawdown | -28.27% | -27.65% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between OPRA and AZN is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
OPRA vs. AZN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Opera Limited (OPRA) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
OPRA vs. AZN - Dividend Comparison
OPRA's dividend yield for the trailing twelve months is around 4.26%, more than AZN's 2.34% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Opera Limited | 4.26% | 9.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AstraZeneca PLC | 2.34% | 2.15% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% | 4.72% |
Drawdowns
OPRA vs. AZN - Drawdown Comparison
The maximum OPRA drawdown since its inception was -72.85%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for OPRA and AZN. For additional features, visit the drawdowns tool.
Volatility
OPRA vs. AZN - Volatility Comparison
Opera Limited (OPRA) has a higher volatility of 13.66% compared to AstraZeneca PLC (AZN) at 9.32%. This indicates that OPRA's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
OPRA vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Opera Limited and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities